Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in Partially Lesioned Rat Model of Parkinson's disease: An Electrophysiological study of substantia nigra dopamine neurons

Chinese Journal of Physiology

Volumn 54, Issue 2, 2011, Pages 96-104

  Gui, Zhen Hua ^a   Liu, Jian ^a   Wang, Yong ^a   Ali, Umar ^a   Wang, Tao ^a   Chen, Li ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apomorphine; Extracellular recording; Parkinson's disease; Subtantia nigra; Tyrosine hydroxylase

Indexed keywords

APOMORPHINE; DESIPRAMINE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RAT; SENSITIVITY ANALYSIS; SUBSTANTIA NIGRA PARS COMPACTA; SYSTEMIC THERAPY; ACTION POTENTIAL; ANIMAL; CELL COUNT; DISEASE MODEL; METABOLISM; NERVE CELL; PARKINSONISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

ACTION POTENTIALS; ANIMALS; APOMORPHINE; CELL COUNT; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; MALE; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

EID: 79551524659     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM014     Document Type: Article

References (30)

1. Acheson, A.L., Zigmond, M.J. and Stricker, E.M. Compensatory increase in tyrosine-hydroxylase activity in rat-brain after intraventricular injections of 6-hydroxydopamine. Science 207: 537- 538, 1980.
2. Akaoka, H., Charlety, P., Saunier, C.F., Buda, M. and Chouvet, G. Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors. Neuroscience 49: 879-891, 1992.
3. Battaglia, G., Busceti, C.L., Cuomo, L., Giorgi, F.S., Orzi, F., De Blasi, A., Nicoletti, F., Ruggieri, S. and Fornai, F. Continuous subcutaneous infusion of apomorphine rescues nigrostriatal dopaminergic terminals following MPTP injection in mice. Neuropharmacology 42: 367-373, 2002.
4. Bilbao, G., Ruiz-Ortega, J.A., Miguens, N., Ulibarri, I., Linazasoro, G., Gomez-Urquijo, S., Garibi, J. and Ugedo, L. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: Effects of subthalamotomy and levodopa treatment. Brain Res. 1084: 175-184, 2006.
5. Bozzi, Y. and Borrelli, E. Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci. 29: 167-174, 2006.
6. Carman, L.S., Gage, F.H. and Shults, C.W. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 553: 275-283, 1991.
7. Chen, J.F., Aloyo, V.J. and Weiss, B. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54: 669-680, 1993.
8. Chritin, M., Blanchard, V., RaismanVozari, R., Feuerstein, C., Agid, Y., Javoy-Agid, F. and Savasta, M. DA uptake sites, D1, and D2 receptors, D2 and preproenkephalin mRNAs and fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration. Eur. J. Neurosci. 8: 2511-2520, 1996.
9. Creese, I. and Synder, S.H. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding. Eur. J. Pharmacol. 56: 277-281, 1979.
10. Depino, A.M., Earl, C., Kaczmarczyk, E., Ferrari, C., Besedovsky, H., del Rey, A., Pitossi, F.J. and Oertel, W.H. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur. J. Neurosci. 18: 2731-2742, 2003.
11. Fornai, F., Battaglia, G. and Gesi, M. Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage. Brain Res. 898: 29-35, 2001.
12. Gassen, M., Glinka, Y., Pinchasi, B. and Youdim, M.B.H. Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur. J. Pharmacol. 308: 219-225. 1996.
13. Gassen, M., Gross, A. and Youdim, M.B.H. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine. Mov. Disord. 13: 242-248, 1998.
14. Grace, A.A. and Bunney, B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10: 301-315. 1983.
15. Grunblatt, E., Mandel, S. and Maor, G. Effects of R- and S apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss. J. Neurochem. 77: 146-156, 2001.
16. Guo, H., Tang, Z.S., Yu, Y., Xu, L., Jin, G.Z. and Zhou, J.W. Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. Eur. J. Neurosci. 16: 1861-1870, 2002.
17. Hollerman, J.R. and Grace, A.A. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res. 533: 203-212, 1990.
18. Kirik, D., Rosenblad, C. and Bjorklund, A. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur. J. Neurosci. 12: 3871-3882, 2000.
19. Nisenbaum, E.S., Stricker, E.M., Zigmond, M.J. and Berger, T.W. Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: Relation to behavioral recovery. Brain Res. 398: 221-230, 1986.
20. Paxinos, G. and Watson, C. The Rat Brain in Stereotaxic Coordinates. 5th ed New York, Academic Press, 2005.
21. Pucak, M.L. and Grace, A.A. Partial dopamine depletions result in an enhanced sensitivity of residual dopamine neurons to apomorphine. Synapse 9: 144-155, 1991.
22. Rudissaar, R., Harro, J., Pruus, K., Rinken, A. and Allikmets, L. Repeated administration of the dopaminergic agonist apomorphine: development of apomorphine aggressiveness and changes in the interaction between dopamine D2 receptors and G-proteins. Pharmacol. Rep. 60: 827-833, 2008.
23. Tepper, J.M., Sun, B.C., Martin, L.P. and Creese, I. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci. 17: 2519- 2530, 1997.
24. Ubeda, A., Montesinos, C., Paya, M. and Alcaraz, M.J. Ironreducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines. Free Radical Bio. Med. 15: 159-167, 1993.
25. Wang, S., Zhang, Q.J., Liu, J., Wu, Z.H., Wang, T., Gui, Z.H., Chen, L. and Wang, Y. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT1A receptor stimulation in the rat. Neuroscience 159: 850-861, 2009.
26. Yuan, H., Sarre, S., Ebinger, G. and Michotte, Y. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDAlesion rat model of Parkinson's disease. Brain Res. 1026: 95-107, 2004.
27. Yuan, H., Sarre, S., Ebinger, G. and Michotte, Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J. Neurosci. Meth. 144: 35-45, 2005.
28. Zhang, W.Q., Tilson, H.A., Nanry, K.P., Hudson, P.M., Hong, J.S. and Stachowiak, M.K. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res. 461: 335-342, 1988.
29. Zigmond, M.J., Acheson, A.L., Stachowiak, M.K. and Stricker, E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal-model of preclinical parkinsonism. Arch. Neurol. 41: 856-861, 1984.
30. Zigmond, M.J., Berger, T.W., Grace, A.A. and Stricker, E.M. Compensatory responses to nigrostriatal bundle injury-studies with 6-hydroxydopamine in an animal-model of parkinsonism. Mol. Chem. Neuropath. 10: 185-200, 1989.